Index of reports
> Cases with Maternal Exposure During Pregnancy (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viread (Tenofovir Disoproxil) where reactions include maternal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Viread side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: 36 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Induced
Drug(s) suspected as cause:
Epivir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiviral Treatment
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Possible Viread side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Combivir
Dosage: 2 df, unk
Administration route: Oral
Start date: 2012-05-28
Isentress
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-28
End date: 2012-05-23
Kaletra
Dosage: 4 df, unk
Administration route: Oral
Start date: 2012-05-28
Viread
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-03-28
End date: 2012-05-23
Possible Viread side effects in 37 year old female
Reported by a health professional (non-physician/pharmacist) from Argentina on 2012-08-08
Patient: 37 year old female
Reactions: Endometrial Disorder, Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Epivir
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-09-21
Kaletra
Dosage: 4tab unknown
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-09-21
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-09-21
Possible Viread side effects in 35 year old female
Reported by a physician from Mexico on 2012-08-06
Patient: 35 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-05-28
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-05-28
Raltegravir
Dosage: 400mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-28
End date: 2012-05-23
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-28
End date: 2012-05-23
Possible Viread side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient:
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Combivir
Dosage: unk df, unk
Administration route: Oral
Start date: 2012-05-28
Isentress
Dosage: unk mg, unk
Administration route: Oral
Start date: 2012-03-28
End date: 2012-05-23
Kaletra
Dosage: unk df, unk
Administration route: Oral
Start date: 2012-05-28
Viread
Dosage: unk mg, unk
Administration route: Oral
Start date: 2012-03-28
End date: 2012-05-23
Possible Viread side effects in 35 year old female
Reported by a health professional (non-physician/pharmacist) from Mexico on 2012-07-23
Patient: 35 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-05-28
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-05-28
Reyataz
Dosage: 400mg per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-28
End date: 2012-05-23
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-28
End date: 2012-05-23
Possible Viread side effects in 37 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient: 37 year old female
Reactions: Endometrial Disorder, Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Epivir
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-09-21
Kaletra
Dosage: 4tab unknown
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-09-21
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-09-21
Possible Viread side effects in 44 year old female
Reported by a physician from Thailand on 2012-07-16
Patient: 44 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Epivir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-14
Kaletra
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-14
Norvir
Dosage: 150mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-11-03
End date: 2012-03-12
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-11-03
End date: 2012-03-12
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-11-03
End date: 2012-03-12
Viread
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-14
Possible Viread side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-03
Patient: 44 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Epivir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-14
Kaletra
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-14
Norvir
Dosage: 150mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-11-03
End date: 2012-03-12
Reyataz
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-11-03
End date: 2012-03-12
Truvada
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-11-03
End date: 2012-03-12
Viread
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-14
Possible Viread side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10
Patient: female
Reactions: Intra-Uterine Death, Maternal Exposure During Pregnancy, Inflammation
Adverse event resulted in: death
Drug(s) suspected as cause:
Epivir
Indication: Maternal Exposure During Pregnancy
Kaletra
Indication: Maternal Exposure During Pregnancy
Viread
Indication: Maternal Exposure During Pregnancy
Possible Viread side effects in 39 year old female
Reported by a physician from United States on 2011-10-10
Patient: 39 year old female
Reactions: Thrombosis, Premature Separation of Placenta, Maternal Exposure During Pregnancy, Stillbirth, Inflammation
Drug(s) suspected as cause:
Epivir
Dosage: 300 mg daily, taken at conception
Administration route: Oral
Indication: Antiviral Treatment
Start date: 2010-07-15
Kaletra
Dosage: 4 tablets daily, taken at conception
Administration route: Oral
Indication: Antiviral Treatment
Start date: 2010-07-15
Viread
Dosage: 300 mg daily, taken at conception
Administration route: Oral
Indication: Antiviral Treatment
Start date: 2010-07-15
Possible Viread side effects in male
Reported by a health professional (non-physician/pharmacist) from Argentina on 2011-10-07
Patient: male, weighing 1.6 kg (3.5 pounds)
Reactions: Premature Baby, Maternal Exposure During Pregnancy, Ventricular Septal Defect
Drug(s) suspected as cause:
Kaletra
Dosage: 4tab per day
Indication: HIV Infection
Start date: 2010-02-15
Lamivudine + Zidovudine
Dosage: 2tab per day
Indication: HIV Infection
Start date: 2009-10-15
Nevirapine
Dosage: 400mgd per day
Indication: HIV Infection
Start date: 2009-10-15
End date: 2010-02-15
Viread
Dosage: 300mgd per day
Indication: HIV Infection
Start date: 2010-02-15
Possible Viread side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-05
Patient: female
Reactions: Intra-Uterine Death, Maternal Exposure During Pregnancy, Inflammation
Adverse event resulted in: death
Drug(s) suspected as cause:
Epivir
Indication: Maternal Exposure During Pregnancy
Kaletra
Indication: Maternal Exposure During Pregnancy
Viread
Indication: Maternal Exposure During Pregnancy
|